Giovanni M. D'agostino

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Journal: Dermatology and therapy

Published: December 01, 2025

Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study.

Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study.

Journal: Journal of the American Academy of Dermatology

Published: July 17, 2025

Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.

Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.

Journal: Journal of clinical medicine

Published: February 05, 2025

Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study.

Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study.

Journal: Dermatology and therapy

Published: November 19, 2024

Efficacy and drug survival of tralokinumab in patients with severe atopic dermatitis: an 18-month multicentre study.

Efficacy and drug survival of tralokinumab in patients with severe atopic dermatitis: an 18-month multicentre study.

Journal: Clinical and experimental dermatology

Published: September 23, 2024

A Nodular Melanoma Mimicking a Blue Nevus: A Case Report.

A Nodular Melanoma Mimicking a Blue Nevus: A Case Report.

Journal: Dermatology practical & conceptual

Published: December 10, 2023

Porocarcinoma of the foot: How would you handle this case without Mohs surgery?

Porocarcinoma of the foot: How would you handle this case without Mohs surgery?

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: November 09, 2023

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study.

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study.

Journal: Dermatology and therapy

Published: March 06, 2023

Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study.

Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 15, 2022

Bullous Pemphygoid and Novel Therapeutic Approaches.

Bullous Pemphygoid and Novel Therapeutic Approaches.

Journal: Biomedicines

Published: October 02, 2022

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa.

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa.

Journal: Antibiotics (Basel, Switzerland)

Published: September 06, 2022

Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa.

Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 07, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026